The CERAB technique: tips, tricks and results.

J Cardiovasc Surg (Torino)

Vascular Clinic ZNA, ZNA Stuivenberg Hospital, Antwerp, Belgium -

Published: June 2016

In this article we wanted to present an overview of the latest study results, in vitro and in vivo, of the Covered Endovascular Reconstruction of the Aortic Bifurcation or CERAB technique and the C-CERAB or Chimney CERAB for the endovascular treatment of either extensive occlusive aortoiliac or iuxtarenal disease with preservation of visceral arteries; in combination with tips and tricks to facilitate recanalization and revascularization. A review was performed of the literature of the last 5 years regarding the endovascular treatment of aortoiliac and iuxtarenal TASC II C& D lesions with covered balloon expandable stents. Furthermore we did a retrospective analysis of our most special techniques to achieve a successful interventional recanalization of these challenging lesions. Both the in vitro and the in vivo studies pointed out that there exists an important benefit of the CERAB configuration with excellent patency rates at one and two years in combination with very low mortality and morbidity, when compared to other techniques. Also the C-CERAB variant seems to be a feasible and safe option; 100% technical success; to deal with iuxtarenal or extensive aortic occlusive disease together with the safeguarding of visceral arteries. The CERAB and C-CERAB techniques may change the treatment algorithm of extensive aortoiliac occlusive disease in the near future and appears to be a safe and feasible alternative with promising results, together with a more anatomical and physiological reconstruction of the aortic bifurcation, being a valid alternative for surgery and/or kissing stents. A few critical issues still need to be solved, such as cost-effectiveness, patient selection, fine-tuning of the technique and defining the optimal medical support.

Download full-text PDF

Source

Publication Analysis

Top Keywords

cerab technique
8
tips tricks
8
vitro vivo
8
reconstruction aortic
8
aortic bifurcation
8
endovascular treatment
8
aortoiliac iuxtarenal
8
visceral arteries
8
occlusive disease
8
cerab
5

Similar Publications

Article Synopsis
  • The study investigated the two-year outcomes of the covered endovascular reconstruction (CERAB) procedure for patients with complex aortoiliac occlusive disease, focusing on a group of 40 patients.
  • All patients had a 100% technical success rate with notable improvements in clinical symptoms observed during the follow-up period.
  • The patency rates at 36 months were favorable, with primary patency at 85%, indicating that CERAB is effective for treating advanced aorto-occlusive conditions.
View Article and Find Full Text PDF
Article Synopsis
  • Treating atherosclerotic occlusive disease in the infrarenal aorta is challenging, with traditional open surgery posing high risks for morbidity and mortality.
  • The American College of Cardiology (ACC)/American Heart Association (AHA) classification helps assess patient risk, especially benefiting high-risk patients through advancements in endovascular technologies.
  • Minimally invasive methods, such as chimney-CERAB, have been effectively used to treat patients with aortoiliac occlusive disease while preserving key blood vessels like the inferior mesenteric artery.
View Article and Find Full Text PDF
Article Synopsis
  • This review evaluated the effectiveness and safety of bifurcated endografts for treating aortoiliac disease (AOID) by analyzing multiple studies across various databases.* -
  • Ten studies involving 365 patients primarily used the AFX endograft, showing high primary patency rates at 12, 24, and 36 months, with estimates around 90-94% and low rates of major complications.* -
  • While the initial findings suggest that bifurcated endografts are a promising option for AOID treatment, further research is needed to conclusively determine their long-term efficacy and safety.*
View Article and Find Full Text PDF

Background And Aims: There has been hesitancy among people with regard to accepting vaccines, especially that of coronavirus disease-2019 (COVID-19). This hesitancy is aggravated by the different vaccine alternatives available and what one considers before choosing a particular vaccine. The aim of this article was to investigate some driving factors that can influence an individual's COVID-19 vaccine preference in the presence of other alternatives, using some specific vaccine characteristics.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the effectiveness of BeGraft and Solaris stent grafts during a specific endovascular treatment called BS-CERAB, aimed at patients with aortoiliac occlusive disease from January 2020 to December 2023.
  • - A total of 42 patients (mostly men, average age 72) participated, with symptoms mainly including intermittent claudication and critical limb ischemia, and all procedures were successful with an average follow-up of 14 months.
  • - Results showed improvement in blood flow (ABI increase) and promising patency rates at 3, 6, and 12 months post-surgery, although active cancer was identified as a risk factor for restenosis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!